Cargando…

Serotonin in the Frontal Cortex: A Potential Therapeutic Target for Neurological Disorders

Detalles Bibliográficos
Autores principales:	Lu, Hui, Liu, Qing-song
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531193/ https://www.ncbi.nlm.nih.gov/pubmed/28758051 http://dx.doi.org/10.4172/2167-0501.1000e184

Ejemplares similares

Orbito-Frontal Cortex Volumes in Panic Disorder
por: Atmaca, Murad, et al.
Publicado: (2012)

Serotonin Receptors as Therapeutic Targets for Autism Spectrum Disorder Treatment
por: Lee, Ansoo, et al.
Publicado: (2022)

Therapeutic Antidepressant Potential of NONHSAG045500 in Regulating Serotonin Transporter in Major Depressive Disorder
por: Liu, Song, et al.
Publicado: (2018)

Mechanism and therapeutic potential of targeting cGAS-STING signaling in neurological disorders
por: Huang, Yige, et al.
Publicado: (2023)

Acute sleep deprivation upregulates serotonin 2A receptors in the frontal cortex of mice via the immediate early gene Egr3
por: Zhao, Xiuli, et al.
Publicado: (2022)

Target Genes of Autism Risk Loci in Brain Frontal Cortex
por: Sun, Yan, et al.
Publicado: (2019)

Targeting pericytes for therapeutic approaches to neurological disorders
por: Cheng, Jinping, et al.
Publicado: (2018)

Insights on therapeutic potential of clemastine in neurological disorders
por: Jiang, Sufang, et al.
Publicado: (2023)

LINGO-1 and AMIGO3, potential therapeutic targets for neurological and dysmyelinating disorders?
por: Foale, Simon, et al.
Publicado: (2017)

Exploring the Effects of Temperament on Gray Matter Volume of Frontal Cortex in Patients with Mood Disorders
por: Yang, Tao, et al.
Publicado: (2021)

A frontal cortex event-related potential driven by the basal forebrain
por: Nguyen, David P, et al.
Publicado: (2014)

Frontal lobe neurology and the creative mind
por: de Souza, Leonardo C., et al.
Publicado: (2014)

The Golgi Apparatus May Be a Potential Therapeutic Target for Apoptosis-Related Neurological Diseases
por: He, Qiang, et al.
Publicado: (2020)

Complement in neurological disorders and emerging complement-targeted therapeutics
por: Dalakas, Marinos C., et al.
Publicado: (2020)

Epigenetic modifications in frontal cortex from Alzheimer's disease and bipolar disorder patients
por: Rao, J S, et al.
Publicado: (2012)

Astrocytes in Neuropathologies Affecting the Frontal Cortex
por: Peteri, Ulla-Kaisa, et al.
Publicado: (2019)

Therapeutic Potential of Salvinorin A and Its Analogues in Various Neurological Disorders
por: Cichon, Joseph, et al.
Publicado: (2022)

Golgi Apparatus: A Potential Therapeutic Target for Autophagy-Associated Neurological Diseases
por: Deng, Shuwen, et al.
Publicado: (2020)

IGF-1 and GLP-1 signaling: potential therapeutic target for neurological disorders – correspondence
por: Gajwani, Neeraj, et al.
Publicado: (2023)

Therapeutic potential for KCC2-targeted neurological diseases()
por: Tomita, Kazuo, et al.
Publicado: (2023)

Regulatory mechanisms and therapeutic potential of JAB1 in neurological development and disorders
por: Yang, Yu, et al.
Publicado: (2023)

Mesenchymal stromal cells as a potential therapeutic for neurological disorders()
por: Mukai, Takeo, et al.
Publicado: (2018)

Integration of landmark and saccade target signals in macaque frontal cortex visual responses
por: Schütz, Adrian, et al.
Publicado: (2023)

The functional connectivity of the middle frontal cortex predicts ketamine’s outcome in major depressive disorder
por: Zhang, Fan, et al.
Publicado: (2022)

Multiple Sclerosis and Serotonin: Potential Therapeutic Applications
por: San Hernandez, Aleyda M, et al.
Publicado: (2020)

An inhibitory pull-push circuit in frontal cortex
por: Garcia-Junco-Clemente, Pablo, et al.
Publicado: (2017)

Face selective patches in marmoset frontal cortex
por: Schaeffer, David J., et al.
Publicado: (2020)

Fluency and rule breaking behaviour in the frontal cortex
por: Cipolotti, Lisa, et al.
Publicado: (2020)

Transcriptome alterations in myotonic dystrophy frontal cortex
por: Otero, Brittney A., et al.
Publicado: (2021)

The Serotonin-6 Receptor as a Novel Therapeutic Target
por: Yun, Hyung-Mun, et al.
Publicado: (2011)

Activation of GSK‐3 disrupts cholinergic homoeostasis in nucleus basalis of Meynert and frontal cortex of rats
por: Wang, Yue, et al.
Publicado: (2017)

Neuroprotective Potential of Chrysin: Mechanistic Insights and Therapeutic Potential for Neurological Disorders
por: Mishra, Awanish, et al.
Publicado: (2021)

Serotonin in the orbitofrontal cortex enhances cognitive flexibility
por: Hyun, Jung Ho, et al.
Publicado: (2023)

Panax ginseng as a potential therapeutic for neurological disorders associated with COVID-19; Toward targeting inflammasome
por: Shin, Seo Won, et al.
Publicado: (2023)

Taurine and its analogs in neurological disorders: Focus on therapeutic potential and molecular mechanisms
por: Jakaria, Md., et al.
Publicado: (2019)

Frontal Cortex-Like Functions of the Subthalamic Nucleus
por: Baunez, Christelle, et al.
Publicado: (2011)

Proactive and reactive control by the medial frontal cortex
por: Stuphorn, Veit, et al.
Publicado: (2012)

Right inferior frontal cortex: addressing the rebuttals
por: Aron, Adam R., et al.
Publicado: (2014)

Conserved Sequence Processing in Primate Frontal Cortex
por: Wilson, Benjamin, et al.
Publicado: (2017)

Neurological disorders and therapeutics targeted to surmount the blood–brain barrier
por: Kanwar, Jagat R, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_4fu1b1i1k4ic4g8r0su5t6md4r